{
  "@context": {
    "bsc": "http://bioschemas.org/",
    "edam": "http://edamontology.org/",
    "rdf": "http://www.w3.org/1999/02/22-rdf-syntax-ns#",
    "rdfs": "http://www.w3.org/2000/01/rdf-schema#",
    "sc": "http://schema.org/",
    "xsd": "http://www.w3.org/2001/XMLSchema#"
  },
  "@graph": [
    {
      "@id": "https://bio.tools/SAMPL",
      "@type": "sc:SoftwareApplication",
      "sc:applicationSubCategory": [
        {
          "@id": "edam:topic_2275"
        },
        {
          "@id": "edam:topic_3277"
        },
        {
          "@id": "edam:topic_0209"
        }
      ],
      "sc:citation": [
        {
          "@id": "https://doi.org/10.1080/10610278.2018.1549327"
        },
        "pubmed:31555042",
        "pmcid:PMC6760852"
      ],
      "sc:description": "> MEDIUM CONFIDENCE! | reference data for the sixth statistical assessment of modeling of proteins and ligands (SAMPL6) | From Wikipedia, the free encyclopedia | Jump to navigation Jump to search | SAMPL (Statistical Assessment of the Modeling of Proteins and Ligands) is a set of community-wide blind challenges aimed to advance computational techniques as standard predictive tools in rational drug design.[1][2][3][4][5] A broad range of biologically relevant systems with different sizes and levels of complexities including proteins, host guest complexes, and drug-like small molecules have been selected to test the latest modeling methods and force fields in SAMPL",
      "sc:featureList": [
        {
          "@id": "edam:operation_3642"
        },
        {
          "@id": "edam:operation_0455"
        },
        {
          "@id": "edam:operation_0482"
        }
      ],
      "sc:name": "SAMPL",
      "sc:url": "https://en.wikipedia.org/wiki/SAMPL_Challenge"
    },
    {
      "@id": "https://doi.org/10.1080/10610278.2018.1549327",
      "@type": "sc:CreativeWork"
    }
  ]
}